Trials / Completed
CompletedNCT02825875
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- Male
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study we aim to more precisely define the clinical utility of PSMA imaging across a range of clinical indications in men with prostate cancer. To accomplish this, we will make the 18F-DCFPyL PET/CT scan available to urologists, medical oncologists, and radiation oncologists at Johns Hopkins and survey physicians as to the indication for ordering the PET/CT and if a change in management occurred as the result of new information gained from the scan. We believe these data will prove critical for planning future studies aimed at evaluating the efficacy of this test for improving patient outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F DCFPyL- Radiopharmaceutica |
Timeline
- Start date
- 2016-06-08
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2016-07-07
- Last updated
- 2020-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02825875. Inclusion in this directory is not an endorsement.